Duodenal-type follicular lymphoma in 18 F-FDG PET/CT imaging: a case report.

Autor:	Huang W; Department of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China., Chao F; Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052, Henan, PR China., Peng Y; Department of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China., Zhang X; Department of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China., Yang Q; Department of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China., Song L; Department of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China., Li L; Department of Radiology, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052, Henan, PR China., Kang L; Department of Nuclear Medicine, Peking University First Hospital Beijing 100034, PR China.
Jazyk:	angličtina
Zdroj:	American journal of nuclear medicine and molecular imaging [Am J Nucl Med Mol Imaging] 2023 Aug 15; Vol. 13 (4), pp. 164-170. Date of Electronic Publication: 2023 Aug 15 (Print Publication: 2023).
Abstrakt:	Follicular lymphoma (FL) is a subtype of non-Hodgkin lymphoma (NHL) that is typically characterized by a slow-growing course. Duodenal-type follicular lymphoma (D-FL) was recently reclassified as a distinct variant. This subtype exhibits unique clinical and biological characteristics, which set it apart from other forms of FL. We report a case of a 36-year-old male patient with multiple, small, gray polypoid lesions in the descending duodenum which were detected by esophagogastroduodenoscopy. The pathological diagnosis was low-grade D-FL. 18 F-FDG PET/CT was performed for staging and revealed the pancreas and peripheral lymph nodes were involved by FL, with a clinical IV stage. The patient underwent a bone marrow smear cytology, which revealed no bone marrow abnormalities, and excluded bone marrow involvement. He was treated with six cycles of chemotherapy using the R-CHOP regimen and reached complete remission. Competing Interests: None. (AJNMMI Copyright © 2023.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu